At Vertex, we believe it is important to recognize moments of great scientific achievement – ones that are often stepping stones on the long and unpredictable path that can lead to the development of new medicines. This year, as part of our seventhannual Outstanding Research Award, we’re proud to recognize four exceptional scientists who have dedicated the past four years to the research and discovery of a novel mechanism with thepotential to selectively target cancer cells.
The Vertex Outstanding Research Award is presented annually to an individual or research team demonstrating an exceptional contribution to solve a critical scientific problem and/or rapidly advance innovation within the global scientific community.
This year’s winners, Russ Hoover, Mac Johnson, Marina Penney and Darin Takemoto, joinedforces in 2012 after the surprising results of a phenotypic screen. Representing cross-functional groups across Research and Global Medicines Development and Affairs, they poured countless hours into research they knew might never come to fruition. However, their persistence paid off in identifying an entirely novel target for cancer therapy. If successful their work could lead to a new personalized medicine for people with certain types of cancer.
“The project recognized this year embodies the Vertex culture – scientists across various disciplines all focused on the same goal of discovering new ways tohelp people with serious and life-threatening diseases,” said David Altshuler, M.D., Ph.D., Executive Vice President of Global Research and Chief Scientific Officer at Vertex. “We’re proud of the work this team has accomplished.”